Abstract:Accumulating evidence suggests that stress-dose corticosteroids impair fear memory in animals and humans. Corticosteroid treatment after critical illness is seen as a potential psychotropic medication by which to prevent posttraumatic stress disorder. However, individual difference in the responsiveness to stress (i.e., stress reactivity) is a factor that modulates the efficacy of corticosteroids. To understand the contribution of fear reactivity to the effect of post-stress corticosterone, male Sprague-Dawley rats were subjected to classical tone-cued fear conditioning and separated into high and low reactivity (HR and LR, respectively) responder groups based on their levels of freezing during conditioning. The HR rats showed significantly higher fear responses than the LR rats during conditioning as assessed by freezing behavior. At two intervals, 30 min and 48 hr later, the HR rats still displayed more pronounced conditioned responses to cued stimuli compared with the LR rats. Moreover, in contrast to the LR rats, the enhanced fear response in the HR rats was difficult to attenuate by post-training high-dose corticosterone. These results suggest that fear reactivity results in stronger fear memory, and that it is difficult to disrupt this strong fear memory in the HR phenotype using monotherapy. However, the strong fear memory in the HR rats was impaired by concurrent intramedial prefrontal cortex infusion of a high dose of the dopamine D-1 receptor antagonist SCH 23390 and systemic administration of corticosterone. SCH 23390 and corticosterone alone did not decrease freezing levels in the HR rats. The fear impairment induced by SCH 23390 combined with corticosterone was not attributable to the effect of these drugs on locomotor activity. This effect was not found with administration of the D-2 antagonist eticlopride combined with corticosterone. Our findings demonstrate that the conditioned fear memory in individuals with high stress reactivity is difficult to disrupt using monotherapy, but that combined pharmacotherapy may be useful for treating intervention-resistant fear.

Both mineralocorticoid and glucocorticoid receptors regulate emotional memory in mice.

Blocking Mineralocorticoid Receptors Prior to Retrieval Reduces Contextual Fear Memory in Mice

The infralimbic mineralocorticoid blockage prevents the stress-induced impairment of aversive memory extinction in rats

Elevated corticosterone after fear learning impairs remote auditory memory retrieval and alters brain network connectivity

Glucocorticoid effects on memory consolidation depend on functional interactions between the medial prefrontal cortex and basolateral amygdala

Systemic corticosterone administration impairs the late fear memory reconsolidation via basolateral amygdala glucocorticoid receptors: Dependence on the time window and memory age

Corticosterone Combined with Intramedial Prefrontal Cortex Infusion of SCH 23390 Impairs the Strong Fear Response in High-Fear-reactivity Rats.

Sex and Age Differences in Glucocorticoid Signaling After an Aversive Experience in Mice

Chronic Corticosterone Administration-Induced Mood Disorders in Laboratory Rodents: Features, Mechanisms, and Research Perspectives

Regulation of excitatory synapses and fearful memories by stress hormones.

Predicting Aversive Events And Terminating Fear In The Mouse Anterior Cingulate Cortex During Trace Fear Conditioning

Glucocorticoid Receptors in the Basolateral Nucleus of Amygdala Are Required for Postreactivation Reconsolidation of Auditory Fear Memory

Glucocorticoid-induced enhancement of contextual fear memory consolidation in rats: Involvement of D1 receptor activity of hippocampal area CA1.

Mtor is Essential for Corticosteroid Effects on Hippocampal AMPA Receptor Function and Fear Memory

Activation of mineralocorticoid receptors facilitate the acquisition of fear memory extinction and impair the generalization of fear memory in diabetic animals

Contributions of Glucocorticoid Receptors in Cortical Astrocytes to Memory Recall

Stress Impairs Reconsolidation Of Drug Memory Via Glucocorticoid Receptors In The Basolateral Amygdala

Combinatorial actions of glucocorticoid and mineralocorticoid stress hormone receptors are required for preventing neurodegeneration of the mouse hippocampus

Genomic glucocorticoid receptor effects guide acute stress-induced delayed anxiety and basolateral amygdala spine plasticity in rats

Corticosteroid Effects on Glutamatergic Transmission and Fear Memory

The Roles of SGK and GR in the Spatial Learning and Memory Enhancement